Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MDVN > SEC Filings for MDVN > Form 8-K on 25-Oct-2012All Recent SEC Filings

Show all filings for MEDIVATION, INC.



Other Events

Item 8.01 Other Events.

Medivation, Inc. today announced that its alliance partner Astellas Pharma Inc. informed Medivation that in accordance with Tokyo Stock Exchange rules, Astellas will be reporting financial results for its fiscal quarter ending September 30, 2012 at 1:00am Eastern Time on Thursday, November 1, 2012 which will include net sales of XTANDI (enzalutamide) capsules for the quarter and guidance on anticipated net sales of XTANDI for Astellas' fiscal year ending March 31, 2013. Simultaneously with Astellas' release of this information, Medivation will disclose this information through an 8K filing. Medivation will report its own financial results for the quarter ended September 30, 2012 on November 9, 2012.

  Add MDVN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MDVN - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.